Clin Exp Obstet Gyn
-
Clin Exp Obstet Gyn · Jan 1999
Immunohistochemical evaluation of apoptosis in placentae from normal and intrauterine growth-restricted pregnancies.
To investigate the extent of apoptosis within the human placenta in tissues from normotensive term pregnancies and those complicated by intrauterine growth-restriction (IUGR). ⋯ These results might point toward a possible role of apoptosis in the pathophysiology of intrauterine growth-restriction.
-
Clin Exp Obstet Gyn · Jan 1998
Can we reduce repeat caesarean delivery at the Princess Badeea Teaching Hospital in north Jordan?
Our aim was to describe the indications of repeat caesarean delivery and to determine modifiable practice patterns that might lead to fewer repeat caesarean deliveries. ⋯ Our vaginal birth rate after one previous caesarean section was 82.2%. If this rate can be maintained in patients with 2 or 3 previous caesarean deliveries, we can reduce repeat caesarean rates by at least 14% by allowing more patients with 2 or even 3 previous caesarean deliveries to have a trial of labour under appropriate conditions and also proper management of dystocia.
-
Clin Exp Obstet Gyn · Jan 1998
Randomized Controlled Trial Comparative Study Clinical TrialA randomized trial of intracervical prostaglandin gel and intravenous oxytocin in prelabor rupture of membranes with unripe cervix at term.
In order to compare the efficacy of immediate intravenous oxytocin administration and intracervical prostaglandin E2 gel application in premature rupture of membranes with unfavorable cervices at term, 45 term pregnant patients with premature rupture of membranes were randomized into two groups. Twenty women received immediate intravenous oxytocin after cleansing enema while the rest were treated with intracervical prostaglandin E2 gel. Means of maternal age, gestational age, Bishop score at admission and the rates of nulliparity did not show any significant differences between the two groups (p > 0.05). ⋯ Cesarean section rates were 24% in the oxytocin group and 5% in the other (p < 0.05). No infectious morbidity was seen in any case. In conclusion, although delivery is delayed with the intracervical prostaglandin approach, cesarean section rate is lowered without an increase in infectious morbidity.
-
Clin Exp Obstet Gyn · Jan 1997
Case ReportsRare manifestations of the ovarian hyperstimulation syndrome: a report of two cases.
The increasing practice of ovulation induction has made ovarian hyperstimulation syndrome (OHSS) a frequent clinical problem which can also become life-threatening. Two unusual cases of OHSS are described. The first patient presented with a unilateral pleural effusion. The second patient developed severe OHSS after a low-dose protocol with highly purified follicle stimulating hormone (FSH HP) and in the absence of risk factors.
-
Clin Exp Obstet Gyn · Jan 1997
Can fetal fibronectin testing improve the management of preterm labour?
The detection of fetal fibronectin (Ffn) in cervico-vaginal secretions has been proposed as a method to differentiate true from false threatened preterm labour. This study evaluates the impact of tocolysis in the management of threatened preterm labour and compares actual practice in our department with a hypothetical management strategy based upon fetal fibronectin (Ffn) testing. Over a 12 month period, 41 women were admitted in threatened preterm labour with intact membranes before 34 weeks gestation. ⋯ The majority of women receiving tocolysis do not benefit from this treatment regardless of whether tocolysis is based upon clinical judgement. Ffn testing or a non-selective administration policy. Administering tocolysis on the basis of a positive Ffn result would be expected to increase the number of women receiving tocolysis but would make a small improvement in the treatment: potential benefit ratio when compared to "actual practice".